GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Diamond Hill Capital Comments on Medtronic Inc

October 24, 2012 | About:
Holly LaFon

Medical device manufacturer Medtronic, Inc. (MDT) reported results that were in-line with Wall Street analysts' expectations but demonstrated sequential improvement in underlying trends, including sales growth excluding foreign exchange affects. Medtronic's growth prospects benefited from market share gains in the Drug-eluting Stent (DES) business, with a better than expected launch of the Resolute Integrity stent. A focus on the international opportunities, specifically China, should also improve long-term potential.

From Diamond Hill Capital's third quarter Select Fund Commentary.


Rating: 3.2/5 (6 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide